Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate Iontophoresis for Lateral Epicondylitis
NCT06578000Phase 1Recruiting
- Start
- Sep 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of magnesium sulfate in Lateral Epicondylitis (LET) (2 arms). Primary endpoints: Pain intensity at 6 weeks, Muscle power at 6 weeks and 2 more. Started Sep 2024; status: recruiting.
02
Drugs
magnesium sulfate
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT06578000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06578000.